The inaugural Enhanced Games, a competition permitting the use of prohibited performance-enhancing drugs (PEDs), is scheduled to commence in Las Vegas, coinciding with a global increase in the utilization of unregulated peptides and the tightening of anti-doping legislation in several jurisdictions.

首屆「強化運動會」預計在拉斯維加斯開幕，該賽事允許使用禁用的性能增強藥物（PEDs）。與此同時，全球對未受監管胜肽的使用量增加，且多個司法管轄區正收緊反興奮劑立法。

The Enhanced Games, funded by investors including Peter Thiel and Donald Trump Jr., represents a departure from traditional athletic regulation by permitting the administration of FDA-approved substances under medical supervision. The event features 42 athletes, including former Olympic medalists such as Fred Kerley and Ben Proud, competing in swimming, track and field, and strength events. Data indicates that 90.5% of participants are utilizing PEDs, with high prevalence rates for testosterone esters (90.5%) and human growth hormone (79%). The organizers characterize the initiative as a transparent framework for scientific discovery and human performance optimization, offering significant financial incentives, including a $25 million total purse and substantial bonuses for unofficial world record attempts.

「強化運動會」由包括 Peter Thiel 和 Donald Trump Jr. 在內的投資者資助，透過允許在醫療監督下使用 FDA 批准的物質，代表了對傳統體育監管的背離。該賽事共有 42 名運動員參加，包括 Fred Kerley 和 Ben Proud 等前奧運獎牌得主，競賽項目涵蓋游泳、田徑及力量項目。數據顯示，90.5% 的參賽者使用 PEDs，其中睪固酮酯（testosterone esters）的盛行率最高（90.5%），人類生長激素則為 79%。主辦方將此倡議描述為一個透明的科學發現與人類性能優化框架，提供顯著的經濟誘因，包括 2,500 萬美元的總獎金以及針對非官方世界紀錄嘗試的高額獎金。

Conversely, the World Anti-Doping Agency (WADA) and the US Anti-Doping Agency (USADA) have characterized the event as an irresponsible biological experiment. Medical experts, including those from the Mayo Clinic and NYU Grossman School of Medicine, have identified primary risks such as cardiovascular dysfunction and oncogenesis, as well as secondary risks where muscular hypertrophy exceeds the structural integrity of tendons and joints. Furthermore, bioethicists suggest that athlete participation may be driven by financial vulnerability rather than bodily autonomy. There are additional concerns regarding the potential for future genetic interventions, such as CRISPR-Cas9, to induce permanent biological alterations.

相反地，世界反興奮劑組織 (WADA) 與美國反興奮劑機構 (USADA) 將該賽事定調為一場不負責任的生物實驗。醫療專家（包括來自梅約診所 Mayo Clinic 與紐約大學 Grossman 醫學院的專家）指出，主要風險包括心血管功能障礙與腫瘤發生，以及肌肉肥大超過腱與關節結構完整性的次要風險。此外，生物倫理學家建議，運動員的參與可能是受經濟脆弱性驅動，而非基於身體自主權。此外，對於未來基因干預（如 CRISPR-Cas9）可能導致永久性生物改變的情況也存在擔憂。

Parallel to this event, regulatory bodies are addressing the broader societal shift toward 'wellness' peptides. In Australia, Sport Integrity Australia (SIA) and the Therapeutic Goods Administration (TGA) have noted a surge in the importation of unregulated peptides marketed via social media. This has prompted SIA to expand its screening regimes to detect a wider array of metabolites. Similarly, the Indian government has proposed amendments to the National Anti-Doping Act 2022 to criminalize the trafficking and commercial distribution of prohibited substances, introducing prison terms of up to ten years for offenses involving minors, in response to India recording the highest number of anti-doping rule violations in 2023.

與此賽事平行，監管機構正在處理社會向「健康」胜肽轉移的更廣泛趨勢。在澳洲，澳洲體育誠信局 (SIA) 與治療產品管理局 (TGA) 注意到透過社群媒體行銷的未受監管胜肽進口量激增。這促使 SIA 擴大其篩檢機制以偵測更廣泛的代謝物。同樣地，印度政府提議修改《2022 年國家反興奮劑法》，將販運與商業分發禁用物質定為刑事犯罪，針對涉及未成年人的違法行為處以最高十年的監禁，以回應印度在 2023 年記錄到最高反興奮劑規則違規人數的情況。

While the Enhanced Games seek to institutionalize the use of PEDs through medical oversight, global anti-doping authorities continue to implement stricter surveillance and criminal penalties to mitigate the health risks and ethical implications of pharmacological enhancement.

雖然「強化運動會」試圖透過醫療監督將 PEDs 的使用制度化，但全球反興奮劑權威機構仍持續實施更嚴格的監控與刑事處罰，以降低藥理增強帶來的健康風險與倫理影響。